Strata Critical Medical Director Reginald Love Receives RSU Award

What Happened
Reginald Love, a director of Strata Critical Medical, Inc. (SRTA), was granted 37,675 Restricted Stock Units (RSUs) on July 30, 2026. The filing reports the grant at $0.00 (award/grant transaction code A); the RSUs will be settled in common stock upon vesting. This is an award/compensation grant, not an open‑market purchase or sale, so it does not reflect an immediate cash transaction.

Key Details

• Transaction date: July 30, 2026; Form 4 filed August 3, 2026 (timely within required period).
• Grant: 37,675 RSUs reported at $0.00 (award). Aggregate reported cash value: $0 (award reported at $0.00).
• Vesting: 100% of the RSUs vest on the date of the Issuer’s 2027 Annual Meeting of Stockholders (per footnote).
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: Confirms these are RSUs that will convert to shares upon vesting. No 10b5‑1 plan, tax‑withholding, or sale reported.

Context
RSU grants are common director/executive compensation and do not change share ownership until they vest and are settled in stock. Such awards are routine for aligning directors’ interests with shareholders; they are informational rather than a direct buy/sell signal.